Advertisement
Person › Details
Oliver Krautscheid (Mologen AG)
Krautscheid, Oliver (Mologen 201603 Supervisory Board Chairman)
Organisation | Mologen AG | |
Group | Mologen (Group) | |
Product | lefitolimod (MGN1703) | |
Product 2 | cancer immunotherapy (immuno-oncology, I-O) | |
Record changed: 2019-03-30 |
Advertisement
More documents for Oliver Krautscheid
- [1] Mologen AG. (3/27/19). "Press Release: Top Pharma Manager Stefan M. Manth, MD, to Become CEO of Mologen AG". Berlin....
- [2] Mologen AG. (2/13/17). "Press Release: Dr Matthias Baumann MD Appointed as New Chief Medical Officer"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top